Every winter, the respiratory virus RSV lands tens of thousands of babies and young children in hospitals around the country. This year, the outbreak started early. WSJ's Denise Roland explains the challenges of creating an RSV vaccine.
Further Reading:
-GSK Poised for Pfizer Battle in RSV Vaccine Market
-RSV Hospitalizations Surge, Babies Hit Hardest
Learn more about your ad choices. Visit megaphone.fm/adchoices
Fler avsnitt av The Journal.
Visa alla avsnitt av The Journal.The Journal. med The Wall Street Journal & Spotify Studios finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
